Dual inhibitory action of a novel akr1c3 inhibitor on both full-length ar and the variant AR-V7 in enzalutamide resistant metastatic castration resistant prostate cancer

by Kafka, M., Mayr, F., Temml, V., Möller, G., Adamski, J., Höfer, J., Schwaiger, S., Heidegger, I., Matuszczak, B., Schuster, D., Klocker, H., Bektic, J., Stuppner, H., Eder, I.E.
Published 2021